111 related articles for article (PubMed ID: 3002668)
1. Catecholamine, vasoactive intestinal peptide and thyrotrophin-dependent cAMP levels display a different sensitivity to iodothyronines in both normal and pathological human thyroid cells in culture.
Brandi ML; Zonefrati R; Rotella CM; Toccafondi R
Clin Endocrinol (Oxf); 1985 Nov; 23(5):503-9. PubMed ID: 3002668
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
Siperstein AE; Miller RA; Clark OH
Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide stimulation of human thyroid cell function.
Toccafondi RS; Brandi ML; Melander A
J Clin Endocrinol Metab; 1984 Jan; 58(1):157-60. PubMed ID: 6315758
[TBL] [Abstract][Full Text] [Related]
4. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Denereaz N; Lemarchand-Beraud T
Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
[TBL] [Abstract][Full Text] [Related]
5. Unusual antagonistic actions of mixtures of vasoactive intestinal peptide, thyroid-stimulating antibodies, and cholera toxin on adenosine 3',5'-monophosphate accumulation in normal human thyroid cell cultures.
Brandi ML; Rotella CM; Kohn LD; Toccafondi R
J Clin Endocrinol Metab; 1986 Jun; 62(6):1199-205. PubMed ID: 2871039
[TBL] [Abstract][Full Text] [Related]
6. Cultured thyroid cell adenosine 3',5'-cyclic monophosphate response to thyrotropin: loss and restoration of sensitivity to iodide inhibition.
Rapoport B; Adams RJ; Rose M
Endocrinology; 1977 Mar; 100(3):755-64. PubMed ID: 233822
[TBL] [Abstract][Full Text] [Related]
7. Studies of catecholamine effect on cyclic AMP in human cultured thyroid cells: their interaction with thyrotrophin receptor.
Toccafondi RS; Brandi ML; Rotella CM; Zonefrati R
Acta Endocrinol (Copenh); 1983 Jan; 102(1):62-7. PubMed ID: 6130662
[TBL] [Abstract][Full Text] [Related]
8. Interaction of VIPergic and cholinergic receptors in human thyroid cell.
Brandi ML; Tanini A; Toccafondi R
Peptides; 1987; 8(5):893-7. PubMed ID: 2829144
[TBL] [Abstract][Full Text] [Related]
9. Transient lack of response to TSH of human cultured thyroid cells obtained from hyperfunctioning tissue.
Tanini A; Brandi ML; Modigliani U; Rotella CM; Toccafondi R
Acta Endocrinol (Copenh); 1986 Nov; 113(3):346-54. PubMed ID: 3024436
[TBL] [Abstract][Full Text] [Related]
10. VIP and hormone secretion from thyroidal follicular and C-cells.
Laurberg P
Horm Metab Res; 1986 Apr; 18(4):230-3. PubMed ID: 2872150
[TBL] [Abstract][Full Text] [Related]
11. Functional properties of human thyroid follicles cultured within collagen gel.
Massart C; Hody B; Condé D; Leclech G; Edan G; Nicol M
Mol Cell Endocrinol; 1988 Apr; 56(3):227-34. PubMed ID: 2836248
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptidergic control of cyclic AMP accumulation in human thyroid cell.
Brandi ML; Toccafondi R
Peptides; 1985; 6(4):641-4. PubMed ID: 2415954
[TBL] [Abstract][Full Text] [Related]
13. Exposure of thyroid slices to thyroid-stimulating hormone induces refractoriness of the cyclic AMP system to subsequent hormone stimulation.
Shuman SJ; Zor U; Chayoth R; Field JB
J Clin Invest; 1976 May; 57(5):1132-41. PubMed ID: 177452
[TBL] [Abstract][Full Text] [Related]
14. Interaction between iodothyronines and thyrotropin receptor in human cultured thyroid cells.
Rotella CM; Tanini A; Zonefrati R; Toccafondi R
J Recept Res; 1981-1982; 2(4):367-82. PubMed ID: 6284929
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide treatment that increases thyroid blood flow fails to alter plasma T3 or T4 levels in the rat.
Huffman LJ; Connors JM; White BH; Hedge GA
Neuroendocrinology; 1988 Jun; 47(6):567-74. PubMed ID: 3399036
[TBL] [Abstract][Full Text] [Related]
16. Modulation by catecholamines and thyrotrophin of cyclic AMP response to beta-adrenergic stimulation by cultured porcine thyroid cells.
Dumas D; Charrier B; Margotat A; Mauchamp J
J Endocrinol; 1982 Apr; 93(1):1-9. PubMed ID: 6279753
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
Montpetit CJ; Perry SF
J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
[TBL] [Abstract][Full Text] [Related]
18. Altered thyroidal responsivity to thyrotropin induced by circulating thyroid hormones. A "short-loop" regulatory mechanism?
Yu S; Friedman Y; Richman R; Burke G
J Clin Invest; 1976 Mar; 57(3):745-55. PubMed ID: 175094
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thyrotropin- and dibutyryl cyclic AMP-induced secretion of thyroxine and triiodothyronine by catecholamines.
Maayan ML; Debons AF; Krimsky I; Volpert EM; From A; Dawry F; Siclari E
Endocrinology; 1977 Jul; 101(1):284-91. PubMed ID: 193681
[TBL] [Abstract][Full Text] [Related]
20. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on cyclic AMP accumulation in sheep pituitary cells in vitro.
Sawangjaroen K; Sernia C; Curlewis JD
J Endocrinol; 1996 Mar; 148(3):545-52. PubMed ID: 8778233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
